FDA warning letter
Issue date
29 Jan 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
19 Feb 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Headquarters
Issue date
Issuing office
Posted date
Subject
Products & Services